☆ 4.6 Review

CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: A systematic review and external validation study

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Related references

Note: Only part of the references are listed.

Article Oncology

Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer

Benjamin Tournier et al.

Summary: Using DNA methylation-based screening, researchers have developed a classifier that can segregate stage II colon cancer into four sub-classes. They identified hypermethylation at specific CpG sites in CDH17 and LRP2 genes that independently confer increased or reduced risk of cancer recurrence. Functional enrichment and immune cell infiltration analyses revealed distinct molecular features in each sub-class.

CANCERS (2023)

Add to Collection

Article Oncology

DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer

Huichuan Yu et al.

Summary: This study demonstrated the prognostic significance of DNA methylation in early-stage colorectal cancer patients, with MePEC identifying an epigenetic subtype at high risk of recurrence and improving the prognostic accuracy of current clinical variables.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Add to Collection

Article Oncology

Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer

Zhen Ye et al.

Summary: By screening and analyzing colorectal cancer methylation dataset, several potential diagnostic methylation sites were identified. These highly methylated sites were associated with poor prognosis in colorectal cancer patients, but showed weak correlation with individual immune cell infiltration. These findings suggest that methylation sites may be a useful tool for diagnosing colorectal cancer.

BMC CANCER (2023)

Add to Collection

Article Biochemical Research Methods

CoSMeD: a user-friendly web server to estimate 5-year survival probability of left-sided and right-sided colorectal cancer patients using molecular data

Junyi Xin et al.

Summary: The study identified prognostic biomarkers for left-sided and right-sided colorectal cancer patients through multi-omics data analysis, and established a side-specific colorectal cancer survival probability database to lay the foundation for personalized management.

BIOINFORMATICS (2022)

Add to Collection

Review Genetics & Heredity

DNA methylation-based predictors of health: applications and statistical considerations

Paul D. Yousefi et al.

Summary: DNA methylation data is a valuable source for biomarker development, as it varies dynamically in response to various factors and has been widely used in prediction and early detection in diverse health-related fields.

NATURE REVIEWS GENETICS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

CpG Site-Based Signature Predicts Survival of Colorectal Cancer

Jiande Wu et al.

Summary: This study investigated the use of DNA methylation for predicting survival in colorectal cancer (CRC). The researchers discovered signatures of CpG sites and genes associated with CRC and predictive of survival. Functional analysis revealed molecular networks and signaling pathways driving clinical outcomes.

BIOMEDICINES (2022)

Add to Collection

Article Medicine, Research & Experimental

Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer

Zijian Chen et al.

Summary: This study found that the NTRK3 gene promoter was more frequently methylated in CRC, leading to suppressed gene expression. It was confirmed that NTRK3 promoter methylation was associated with survival outcome in CRC and a nomogram predicting survival outcome was developed. Moreover, NTRK3 promoter methylation also predicted survival outcomes in other tumors.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Oncology

Global colorectal cancer burden in 2020 and projections to 2040

Yue Xi et al.

Summary: Colorectal cancer is a major global public health challenge with higher incidence rates in developed countries and increasing trends in middle- and low-income countries. The rise of early-onset colorectal cancer is also seen. Increasing awareness, promoting healthy lifestyle choices, and implementing global screening programs are crucial in reducing the morbidity and mortality of colorectal cancer in the future.

TRANSLATIONAL ONCOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer

Hao Huang et al.

Summary: This study aimed to develop and validate novel methylation prognostic models correlated with different survival indicators for individualized prognosis prediction for CRC patients. The prognostic models were successfully developed and validated in TCGA CRC dataset and an independent CRC dataset, utilizing a combination of selected 3-CpG methylation sites in three genes.

MOLECULAR CARCINOGENESIS (2021)

Add to Collection

Article Oncology

A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer

Dong-hai Li et al.

Summary: This study comprehensively analyzed gene expression and methylation data of CRC samples, identifying DEGs and DMCs associated with CRC and establishing a Cox regression model consisting of 10 CpG sites to predict the prognosis of CRC patients effectively.

CANCER GENETICS (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

A panel of differentially methylated regions enable prognosis prediction for colorectal cancer

Lei Zhang et al.

Summary: The study aimed to identify differentially methylated regions (DMRs) for predicting survival outcomes in CRC patients, and validated the prediction potential of DMRs through targeted bisulfite sequencing. High prognostic index (high-PI) group demonstrated significantly unfavorable prognosis in both TCGA discovery cohort and independent validation cohort.

GENOMICS (2021)

Add to Collection

Review Gastroenterology & Hepatology

Epigenetics of colorectal cancer: biomarker and therapeutic potential

Gerhard Jung et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A novel CpG-methylation-based nomogram predicts survival in colorectal cancer

Xiaokang Wang et al.

EPIGENETICS (2020)

Add to Collection

Article Genetics & Heredity

Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling

Zuojing Yin et al.

FRONTIERS IN GENETICS (2020)

Add to Collection

Article Oncology

Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer

Xiaoyuan Wang et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures

Renshen Xiang et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer

Shu Gong et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Add to Collection

Article Gastroenterology & Hepatology

Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier)

Melanie Guendert et al.

GUT (2019)

Add to Collection

Letter Gastroenterology & Hepatology

Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study

Jihoon E. Joo et al.

GUT (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer

Sonja Neumeyer et al.

EPIGENETICS (2019)

Add to Collection

Article Oncology

A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival

Min Jia et al.

CLINICAL EPIGENETICS (2019)

Add to Collection

Review Medicine, General & Internal

Colorectal cancer

Evelien Dekker et al.

LANCET (2019)

Add to Collection

Article Medicine, General & Internal

PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration

Karel G. M. Moons et al.

ANNALS OF INTERNAL MEDICINE (2019)

Add to Collection

Article Genetics & Heredity

Hypermethylation of N-Acetyltransferase 1 Is a Prognostic Biomarker in Colon Adenocarcinoma

Cheng Shi et al.

FRONTIERS IN GENETICS (2019)

Add to Collection

Article Cell Biology

Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients

Changshun Yang et al.

AGING-US (2019)

Add to Collection

Article Cell Biology

Genome-Wide Network-Based Analysis of Colorectal Cancer Identifies Novel Prognostic Factors and an Integrative Prognostic Index

Xiaolin Hou et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Add to Collection

Article Biochemical Research Methods

ChAMP: updated methylation analysis pipeline for Illumina BeadChips

Yuan Tian et al.

BIOINFORMATICS (2017)

Add to Collection

Article Oncology

Survival analysis in the presence of competing risks

Zhongheng Zhang

ANNALS OF TRANSLATIONAL MEDICINE (2017)

Add to Collection

Review Genetics & Heredity

Profiling genome-wide DNA methylation

Wai-Shin Yong et al.

EPIGENETICS & CHROMATIN (2016)

Add to Collection

Review Genetics & Heredity

DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer

Yutaka Hashimoto et al.

EPIGENOMICS (2016)

Add to Collection

Article Medicine, General & Internal

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

Karel G. M. Moons et al.

ANNALS OF INTERNAL MEDICINE (2015)

Add to Collection

Article Oncology

Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment

Michael Hoffmeister et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Add to Collection

Article Oncology

Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment

Michael Hoffmeister et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Add to Collection

Article Gastroenterology & Hepatology

Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy

Hermann Brenner et al.

GASTROENTEROLOGY (2014)

Add to Collection

Article Pharmacology & Pharmacy

STABILITY INVESTIGATIONS OF MULTIVARIABLE REGRESSION MODELS DERIVED FROM LOW- AND HIGH-DIMENSIONAL DATA

Willi Sauerbrei et al.

JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2011)

Add to Collection

Review Multidisciplinary Sciences

Epigenetics in human disease and prospects for epigenetic therapy

G Egger et al.

NATURE (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.